{"organizations": [], "uuid": "7cf6121dba808959efd77f7ed75c73af82d4d045", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180129.html", "section_title": "Archive News &amp; Video for Monday, 29 Jan 2018 | Reuters.com", "url": "https://www.reuters.com/article/nuuvera-ma-aphria/update-1-weed-company-aphria-to-buy-rival-nuuvera-for-c826-mln-idUSL4N1PO42M", "country": "US", "domain_rank": 408, "title": "UPDATE 1- Weed company Aphria to buy rival Nuuvera for C$826 mln", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.016, "site_type": "news", "published": "2018-01-29T21:27:00.000+02:00", "replies_count": 0, "uuid": "7cf6121dba808959efd77f7ed75c73af82d4d045"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/nuuvera-ma-aphria/update-1-weed-company-aphria-to-buy-rival-nuuvera-for-c826-mln-idUSL4N1PO42M", "ord_in_thread": 0, "title": "UPDATE 1- Weed company Aphria to buy rival Nuuvera for C$826 mln", "locations": [], "entities": {"persons": [], "locations": [{"name": "canada", "sentiment": "none"}, {"name": "uruguay", "sentiment": "none"}, {"name": "aphria", "sentiment": "none"}, {"name": "nuuvera", "sentiment": "none"}, {"name": "italy", "sentiment": "none"}, {"name": "united kingdom", "sentiment": "none"}, {"name": "germany", "sentiment": "none"}, {"name": "spain", "sentiment": "none"}], "organizations": [{"name": "aphria", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "aurora cannabis", "sentiment": "none"}, {"name": "norton rose fulbright canada", "sentiment": "none"}, {"name": "aphria inc", "sentiment": "none"}, {"name": "nuuvera", "sentiment": "none"}, {"name": "clarus securities", "sentiment": "none"}, {"name": "canaccord genuity", "sentiment": "none"}, {"name": "stikeman elliott llp", "sentiment": "none"}, {"name": "nuuvera inc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "(Adds details on deal, background on cannabis industry)\nJan 29 (Reuters) - Canadian cannabis company Aphria Inc on Monday said it would buy rival Nuuvera Inc for C$826 million ($670 million) to expand globally, ahead of Canada’s proposed legalisation of recreational weed by mid 2018.\nThe move comes days after the marijuana industry saw its biggest deal ever, when Aurora Cannabis said it would buy CanniMed for C$1.1 billion. .\nMedical marijuana is already legal in Canada, but the sector is expected to get a boost from exports as many other countries move closer to legalisation.\nAphria will leverage Nuuvera’s network in countries like Germany, Italy, Spain, the United Kingdom and Uruguay to create an international footprint, the companies said.\nAphria will pay C$8.50 per share to Nuuvera shareholders, a 21.4 percent premium to Nuuvera’s Friday close.\nClarus Securities was strategic adviser and Stoic Advisory was financial adviser to Aphria. Stikeman Elliott LLP acted as the company’s legal counsel.\nCanaccord Genuity was financial adviser and Norton Rose Fulbright Canada acted as legal counsel to Nuuvera.\n$1 = 1.2335 Canadian dollars Reporting by Anirban Paul in Bengaluru; Editing by Saumyadeb Chakrabarty and Martina D'Couto\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-01-29T21:27:00.000+02:00", "crawled": "2018-01-30T18:41:45.028+02:00", "highlightTitle": ""}